There were no discrepancies between these patient groups in relation to gender, hypertension, or history of smoking or alcohol intake, or the medications usage including angiotensin-converting enzyme inhibitor or angiotensin receptor blocker (ACEI/ARB), beta blocker, mineralocorticoid receptor antagonist (MRA) or statin. The gene discussed is NR3C2; the disease is hypertensive disorder.